These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 21950989

  • 21. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
    Alviña K, Khodakhah K.
    J Neurosci; 2010 May 26; 30(21):7258-68. PubMed ID: 20505092
    [Abstract] [Full Text] [Related]

  • 22. Upbeat about downbeat nystagmus.
    Halmagyi GM, Leigh RJ.
    Neurology; 2004 Aug 24; 63(4):606-7. PubMed ID: 15326227
    [No Abstract] [Full Text] [Related]

  • 23. RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2.
    Salvi J, Bertaso F, Mausset-Bonnefont AL, Metz A, Lemmers C, Ango F, Fagni L, Lory P, Mezghrani A.
    Neurobiol Dis; 2014 Aug 24; 68():47-56. PubMed ID: 24768804
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological advances in the treatment of neuro-otological and eye movement disorders.
    Strupp M, Brandt T.
    Curr Opin Neurol; 2006 Feb 24; 19(1):33-40. PubMed ID: 16415675
    [Abstract] [Full Text] [Related]

  • 25. Aberrant cerebellar Purkinje cell activity as the cause of motor attacks in a mouse model of episodic ataxia type 2.
    Tara E, Vitenzon A, Hess E, Khodakhah K.
    Dis Model Mech; 2018 Sep 21; 11(9):. PubMed ID: 30279196
    [Abstract] [Full Text] [Related]

  • 26. Introducing treatment strategy for cerebellar ataxia in mutant med mice: combination of acetazolamide and 4-aminopyridine.
    Abbasi S, Abbasi A, Sarbaz Y.
    Comput Methods Programs Biomed; 2014 Feb 21; 113(2):697-704. PubMed ID: 24326337
    [Abstract] [Full Text] [Related]

  • 27. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
    Domínguez-Durán E, Mármol-Szombathy I, Baños-Roldán Ú, Sánchez-Gómez S.
    Acta Otorrinolaringol Esp (Engl Ed); 2020 Feb 21; 71(1):40-44. PubMed ID: 31078225
    [Abstract] [Full Text] [Related]

  • 28. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
    Claassen J, Teufel J, Kalla R, Spiegel R, Strupp M.
    J Neurol; 2013 Feb 21; 260(2):668-9. PubMed ID: 23183922
    [No Abstract] [Full Text] [Related]

  • 29. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
    Helmchen C, Sprenger A, Rambold H, Sander T, Kömpf D, Straumann D.
    Neurology; 2004 Aug 24; 63(4):752-3. PubMed ID: 15326263
    [No Abstract] [Full Text] [Related]

  • 30. Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.
    Helmchen C, Gottschalk S, Sander T, Trillenberg P, Rambold H, Sprenger A.
    J Neurol; 2007 Aug 24; 254(8):1126-8. PubMed ID: 17410325
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurones of rats: behavioural and electrophysiological evidence.
    Janahmadi M, Goudarzi I, Kaffashian MR, Behzadi G, Fathollahi Y, Hajizadeh S.
    Neurotoxicology; 2009 May 24; 30(3):393-402. PubMed ID: 19442824
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
    Kalla R, Glasauer S, Schautzer F, Lehnen N, Büttner U, Strupp M, Brandt T.
    Neurology; 2004 Apr 13; 62(7):1228-9. PubMed ID: 15079036
    [No Abstract] [Full Text] [Related]

  • 38. The first knockin mouse model of episodic ataxia type 2.
    Rose SJ, Kriener LH, Heinzer AK, Fan X, Raike RS, van den Maagdenberg AM, Hess EJ.
    Exp Neurol; 2014 Nov 13; 261():553-62. PubMed ID: 25109669
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.